Covidien Ltd news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

COV 106.71 0.00 (0.00%)
price chart
Baxter Names Jose Almeida, Former Head of Covidien, New CEO
Almeida, a native Brazilian who goes by "Joe," took over as the second CEO of Covidien in 2011 after it was spun off from Tyco International Ltd. in 2007. He first joined the company as director of manufacturing in 1995 and rose to president of ...
Baxter names Jose Almeida, former head of Covidien, as new CEO  Chicago Daily Herald
Baxter International Hires Outsider Jos� Almeida as CEO  Wall Street Journal
The Tax-Shopping Backstory of the Medtronic-Covidien Inversion
A new regime spun off Tyco's health care unit into a separate publicly traded firm, Covidien Ltd., also headquartered in Bermuda.
Medtronic to Buy Device Maker Covidien for $42.9 Billion  Bloomberg
Medtronic snaps up Covidien for $42.9bn  Financial Times
Related articles »  
Covidien to Buy Jerusalem-Based Oridion for $346 Million
Covidien Plc agreed to buy Oridion Systems Ltd., an Israeli maker of devices for patient breathing safety, for $346 million.
Covidien buys medical device maker Oridion  The Deal Pipeline
Covidien acquires Oridion for $346m  Globes
PolyTouch Medical Acquired by Covidien
PolyTouch Medical Ltd., a leading developer of hernia mesh placement technologies, was acquired by Covidien (NYSE: COV), a leading global provider of healthcare products that is traded on the New York Stock Exchange at a current market value of $26 ...
Covidien Announces Definitive Agreement to Acquire Given Imaging
DUBLIN, Ireland & YOQNEAM, Israel--(BUSINESS WIRE)--Covidien plc (NYSE: COV) and Given Imaging Ltd. (Nasdaq: GIVN) today announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for ...
Covidien pays $860M for Israel's Given Imaging  The Deal Pipeline
Covidien buys Given Imaging for $860m  Globes
Related articles »  
Moody's upgrades Covidien's long term rating to A3 from Baa1; outlook negative
New York, January 27, 2015 -- Moody's Investors Service today upgraded the senior unsecured debt ratings of Covidien International Finance SA to A3 from Baa1.
Medtronic: the tax inversion that got away  Financial Times
Medtronic Completes Covidien Acquisition for $50B
Tissue Regenix May Attract Suitors After Covidien Deal
Ongoing clinical studies and initial sales of DermaPure over the next year or two could lead to Tissue Regenix becoming a takeover target, Martin Brunninger, an analyst at Jefferies International Ltd. in London, said in a note to investors on June 12 ...
Related articles »  
Congratulations Covidien: You Escaped In Time
As part of Medtronic in Dublin Ireland (tax rate: 12.5%), Covidien is now beyond Obama's reach. What about the ... Medtronic was vindicated in completing their purchase of Covidien despite the aggressive shakedown that they had to endure. Those who did ...
In Wake of Medtronic's Covidien Deal, Bernstein Asks: Who's Next?
In the wake of Medtronic Inc.'s $43 billion deal for Covidien PLC, analysts at Bernstein are telling investors to expect more deals in the medical-device industry in coming months.
Medtronic Likely To Be Booted From Fortune 500 Over Deal To Move HQ Overseas  Twin Cities Business Magazine
Tax Inversions: Tail Wags Dog?  ValueWalk
Related articles »  
Covidien was once just a piece of giant Tyco
But the combined market value of all the pieces - the surviving Tyco International, Covidien, TE Connectivity Ltd., ADT Corp.